Our latest work highlights how menopause alters insulin sensitivity and diabetes management, yet the intersection remains under-researched. This study explores how menopause stages impact diabetes outcomes.
A dQ&A-CeQur study in Clinical Diabetes finds 2 months on the CeQur Simplicity insulin patch boosts patient satisfaction, cuts burden, and lifts well-being.
This article reports results of a survey of patients and health care providers regarding their experiences of and challenges with the use of basal insulin.
Our research finds Mounjaro patients report health benefits but face confusion and frustration during therapy initiation.
We are excited to announce that the dQ&A team presented eight abstracts at the Advanced Technologies and Treatments for Diabetes (ATTD) 2023 conference.
dQ&A’s Trevor Bell publishes research in Current Diabetes Reports, offering insights into the critical role psychosocial issues play in diabetes management.
Our semi-annual study of digital health apps in diabetes, known as “DHx” (Digital Health Experience), finds broad variation in patient satisfaction.
We're proud to share Evelyn Cox’s EASD 2022 abstract revealing mental-health disparities among Europeans with diabetes by nationality, gender, and age.
Our T2 Insulin Insights is a semi-annual Research Service that explores the lived experience of people with type 2 diabetes who take insulin.
